|Bid||105.00 x 0|
|Ask||108.00 x 0|
|Day's range||105.00 - 105.00|
|52-week range||67.50 - 112.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pfizer is poised to apply for emergency use authorization of its COVID-19 vaccine within days after announcing early Wednesday that the final results of its Phase 3 trial conclude the vaccine is 95% effective.
Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...